Myasthenia gravis: open trials in Netherlands

8 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT05265273
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Leiden University Medical Center, Leiden
Registry updated 2026-11-04
NCT07673627
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
Trial Treatment · Phase 2 · argenx
Leids Universitair Medisch Centrum (LUMC), Leiden
Registry updated 2026-11-04
NCT05374590
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · argenx
Academisch Ziekenhuis Leiden, Leiden
Registry updated 2026-11-03
NCT06392386
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Trial Treatment · Phase 2/3 · argenx
Leids Universitair Medisch Centrum (LUMC), Leiden
Registry updated 2026-09-28
NCT07284420
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Trial Treatment · Phase 2 · argenx
Leids Universitair Medisch Centrum (LUMC), Leiden
Registry updated 2026-09-24
NCT06414954
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Trial Treatment · Phase 2 · NMD Pharma A/S
Leiden Universitair Medisch Centrum (LUMC), Leiden
Registry updated 2026-08-21
NCT06743490
Capturing Key MG-symptoms Using Smartphone Recordings.
Research · Leiden University Medical Center
Leiden University Medical Center, Leiden
Registry updated 2026-07-08
2023-507539-40-00
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
Trial Treatment · Phase 2 · NMD Pharma A/S
Leids Universitair Medisch Centrum (LUMC), Leiden
Registry updated 2026-02-26

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error